Logo Image
News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsShortsSpecial ReportsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Hidradenitis Suppurativa
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Disorders
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • RSV
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Rare Disease
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement
|Articles|May 1, 2000

New Products

Advertisement
Advertisement

Related Content

Advertisement
FDA fast tracks BM-3103 gel for epidermolysis bullosa simplex

FDA fast tracks BM-3103 gel for epidermolysis bullosa simplex

ByMorgan Ebert, Executive Editor
June 24th 2026
Teva submits NDA for ecopipam for pediatric Tourette syndrome

Teva submits NDA for ecopipam for pediatric Tourette syndrome

ByMorgan Ebert, Executive Editor
June 24th 2026
Childhood influences may shape risk for dozens of adult health conditions |Image Credit: © Kaspars Grinvalds- stock.adobe.com.

Childhood influences may shape risk for dozens of adult health conditions

ByMorgan Ebert, Executive Editor
June 24th 2026
FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

ByMorgan Ebert, Executive Editor
June 23rd 2026
New guideline updates care for central precocious puberty | Image Credit: © Vitalii Vodolazskyi- stock.adobe.com.

New guideline updates care for central precocious puberty

ByMorgan Ebert, Executive Editor
June 23rd 2026

Latest CME

 Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more
Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

Recent advances in the treatment of molluscum contagiosum

2

Endocrine-disrupting chemicals detected in breast milk and infant urine through 6 months of age

3

New guideline updates care for central precocious puberty

4

Childhood influences may shape risk for dozens of adult health conditions

5

Teva submits NDA for ecopipam for pediatric Tourette syndrome

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us